{"name":"Nordic Nanovector","slug":"nordic-nanovector","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Betalutin","genericName":"Betalutin","slug":"betalutin","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Betalutin","genericName":"Betalutin","slug":"betalutin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNZ2NzSTVYcVpIUFd2N3lsTUxkVl81SDhVamtER3ZndVRzRHBpRHd6TEVMWmNxOFRoeENLdVVrelRnNGcwOVB6UG95TFJtdWdleEZTdnF4VEtiOWpTR0xjcU9EYkliS0RYZ2RpVkJVQnhhU1BDUmRIcnBHN3lGaWZaM2VVM0w1bF8xZ2Z2V05DZFdTendYaEROMQ?oc=5","date":"2025-09-17","type":"pipeline","source":"Pharmafile","summary":"NeoVac appoints Jan H Egberts as chief executive officer - Pharmafile","headline":"NeoVac appoints Jan H Egberts as chief executive officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxQLUdGNExlVk1Yb25WMVhZWUlQUzgteV93WGRaSHU4WWZzMDFUYURLQXV5dFdHM3JTcERzSVQ5eUlLOFRSTXFsak8xdFJ4RmpHblB6YXJWY0tXMnhrQWluUk5OTkRqWTZvWHB0UkUyMndISW9XSS1tNDhnTDVnZmVxZm1lWUVLM3VVb2Y0dzJ2ZDExNWlhNk84RERxRkJSY2RubzhfSHZPZ3JpQ1NhSWV3ODltTlc3TF9ZWlV4LXFNWV9EdFlOT1RQNnFGeVotT3l3LWhmd2Z1Y19DcmtfQzJqdDlSaFlsZWJhWmlPMVluVkIzTmRPcTQxcDZ1UkhicGVfQUFqZ3QtZHVfTEQ1RXB4UmFkVkRmeXduUU1XQzM2YU5Jb002cnNpb01B?oc=5","date":"2024-11-28","type":"trial","source":"PR Newswire","summary":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOR21GamdYclBPZ2tLbWwya1ZVUi1pUDFHR1hkWjZ0TVlNWUJ4V3JrMkw3YlI5UzNPQk11UEhSVmFIWERtRjBNd3doVlI4WjNsMGdxUGltY3IwZUd2Tks1ZjZPZkx2bjBfQm1kMG9vc0lrOExHZ3RoUmVaSjNneE1aY3pYN01hMl8tME5NczhaclNKZUVEeE1oRnBKWDh5NXlMNUlsc1lsV0dVdmFF?oc=5","date":"2024-03-25","type":"pipeline","source":"Manufacturing Chemist","summary":"Nordic Nanovector appoints Dr Reza Safaei as head of Medical Affairs - Manufacturing Chemist","headline":"Nordic Nanovector appoints Dr Reza Safaei as head of Medical Affairs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5DakpKcjFDY2w4Q2tycWZXMTV2NkYzM0FDYzRxb1BROU04bVo0ZHlHQ3J1ZVFoeVdsVHBrR1l4clIzUzhsSHdQY3VGZGRWUDdTZWZoX2s1OXR2V2NoSzZYajJWUE9SSTJ6U0wyTWlXMi1vWG1aZ2FhcmswTEY?oc=5","date":"2023-11-08","type":"trial","source":"Oncology Pipeline","summary":"Genmab deals another blow to CD37 | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Genmab deals another blow to CD37 | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNa3ZPUTFtNlgyX2RDMGItdWlMa2R0Q3FvTDFLSURuc3hUNkZnT2NBNGJ3N0luanlPbkZhaVE0a0hVdEQtemFtWDhaNzh6NDlIMlpjMmJ4LVloczNnSjNUYWk0Szh6d1FyaEdYM1VUZE5xaW5EZmNEWmZWQzVDSUxpVDVB?oc=5","date":"2023-03-07","type":"regulatory","source":"pharmaphorum","summary":"Swiss biotech Noema raises $112m for Roche castoffs - pharmaphorum","headline":"Swiss biotech Noema raises $112m for Roche castoffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxObDR6NHJ3dlFSMmttaVc1YXBIdkdfblNoZjdCODJoN1lUdnNSUXZpdDhjZ3NwRmlDTlZTeTR1SEVtT1FlcXd0MDR2b3lGNWVnaXphMzRkMkJOcTlVdXZFN29QMG1mOHJ5YlF3RVA5ajA0TTBUZWg1TWpaZkxNQ2JRaXhjVy1UY1pJOV9hM2xlOF9qTHdQellaNFo4NVNBeDZXUHo2U0dwVHltUWhNRXhRNkdwaXRQaDA?oc=5","date":"2022-12-16","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Roche's executive dominoes continue to tip, with pharma leader the latest to exit - Fierce Biotech","headline":"Chutes & Ladders—Roche's executive dominoes continue to tip, with pharma leader the latest to exit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQNkR2N3lvNENsQXhRMWQ3WUdXWUtsc3NIZVhRVTFCUnZMLVhyYi1ON0IwUDAtZWlyanBMaG02aTRDS2RLRzlKdXBFcHpmQjNuTTN2LTN0VHZhMjA4N3lJZFYydzVLay15N0Z4NkVCdjRWUlo2SXZxQXVmZWNYUC1uUWpzSTJkS1ZYeVpfM0QyUmtONlNn?oc=5","date":"2022-12-13","type":"deal","source":"pharmaphorum","summary":"Nordic Nanovector board resigns en masse as merger bid fails - pharmaphorum","headline":"Nordic Nanovector board resigns en masse as merger bid fails","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQOHh2dWhHQTQybERJeFRGVU0zVXhjbEZ5QUdFb1hZb3JJNDZld3dHYjlKdjNudXJMVUZtb044TXlreGRWbHpjRnVxNlV2VV9NRmg3UDl2OVdsZnNGRkxablBzQjMtOEF5TEkwMXI4Mzl4S21LUmNBdllMeTQtQi0zaWp5N1FEeUdKWTVNWU1PYVE?oc=5","date":"2022-11-10","type":"pipeline","source":"pharmaphorum","summary":"Nordic Nanovector to merge with APIM after Betalutin fail - pharmaphorum","headline":"Nordic Nanovector to merge with APIM after Betalutin fail","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQcE9vYjd6SXE5eEoxRGdRT1dqYmpub0d4aVVJVndHeTZLdWtSY1hHcGJfck5BNGM4d0k3X1VqaC1FRk9BZmJtV2FGanNudERQdnMzaXhPZHJuMU5ZUGRZSGdyd1VRM2Y5d1EydXdNZlNBak9nWlJ0YnBVV1RpZ1VuU0NQalpid21mel9IcVBxbm5DR0QyZHJfazFQYVg?oc=5","date":"2020-12-01","type":"regulatory","source":"Fierce Biotech","summary":"Noema bags $60M to take ex-Roche CNS drugs through phase 2b - Fierce Biotech","headline":"Noema bags $60M to take ex-Roche CNS drugs through phase 2b","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPZ3dKWktHN0xtUVUxbmhFaEdSM3JYSzE5VVdzV0V3eUxidVVjdDZoOF85d3BhbE9jWkNiSW9Zcm85WEhCMjEtSzFRM3dOa3U1QVZfZjktOXV3RTlscGhHd2dxMEZfRnhYaGFfckQ2MmsxczFlZUh0UlQtMlhDZjdDakt1ZmlFaTVVZ2ZFQVBIRTh4eEdLUmRJN3dYN3B5ekVyalNnYmpHX3FmQk9V?oc=5","date":"2019-06-25","type":"deal","source":"Contract Pharma","summary":"3P Biopharmaceuticals and Nordic Nanovector Extend Partnership - Contract Pharma","headline":"3P Biopharmaceuticals and Nordic Nanovector Extend Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPVFJZSEhRZjNkYWlENHp4cU5uU09nSjBxcGo4VVNaOGFJdjRsYzNqNnJ1SGdyN3FXOGVuX1gzNy1HeERESHVLd2QxQXljM0Y0bThwM0VWWDc2a2FtRkdhck81TW9CSFlRRkd4XzV5bGx0THVRM2gzRl9Id3VzNUdnMndDSld4ZXJSQlo4OGZZVElMSF9ieDRVMW14TW5jN25NLTE0aWNwVTVYdmtRQ0FnQ3dPeGhKelN4VHc?oc=5","date":"2016-10-13","type":"pipeline","source":"Pharmafile","summary":"Nordic Nanovector announces the appointment of Joanna Horobin as Non-Executive Board Director - Pharmafile","headline":"Nordic Nanovector announces the appointment of Joanna Horobin as Non-Executive Board Director","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}